About Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited started in 2017 with the aim of finding and developing and manufacturing various quantities of specialty and complex pharmaceutical drugs. By March 2024, the firm had already released 54 drugs in strategic therapeutic categories consisting of antibiotics, antibacterials, antifungals, as well as treatment for blood. The company has three R&D facilities, two in India and one in the US. The company is planning to merge these three into a single dedicated facility in Ahmedabad. The company is growing into the future by expanding its Atlanta site through a brownfield project and enhancing its R&D capacity with new laboratory equipment. Besides, it is planning to set up a specialised injectables manufacturing facility in the US for the production and marketing of high-value injectables in the American market.
